These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
34. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Omura G; Blessing JA; Ehrlich CE; Miller A; Yordan E; Creasman WT; Homesley HD Cancer; 1986 May; 57(9):1725-30. PubMed ID: 3513943 [TBL] [Abstract][Full Text] [Related]
35. An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens. Parma G; Mancari R; Del Conte G; Scambia G; Gadducci A; Hess D; Katsaros D; Sessa C; Rinaldi A; Bertoni F; Vitali A; Catapano CV; Marsoni S; van de Velde H; Colombo N Int J Gynecol Cancer; 2012 Jun; 22(5):792-800. PubMed ID: 22635029 [TBL] [Abstract][Full Text] [Related]
36. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697 [TBL] [Abstract][Full Text] [Related]
37. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451 [TBL] [Abstract][Full Text] [Related]
38. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. Piver MS; Lele SB; Marchetti DL; Baker TR; Tsukada Y; Emrich LJ J Clin Oncol; 1988 Jun; 6(6):983-9. PubMed ID: 3373267 [TBL] [Abstract][Full Text] [Related]
39. Management of epithelial ovarian neoplasms using a platinum-based regimen: a 10-year experience. Belinson JL; Lee KR; Jarrell MA; McClure M Gynecol Oncol; 1990 Apr; 37(1):66-73. PubMed ID: 2323615 [TBL] [Abstract][Full Text] [Related]
40. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer]. Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]